Wereport a family with Becker muscular dystrophy (BMD)presenting with cardiac involvement. The proband was a 41-year-old Japanese manwhowas hospitalized with exertional dyspnea and muscle weakness. Cardiac examination showedfindings consistent with dilated cardiomyopathy. Dystrophin immunohistochemical analysis showed a discontinuous patchy staining pattern in cardiac and skeletal muscles biopsied from the proband. His brothers had high creatine kinase (CK) activity and abnormal electrocardiogram.
Introduction
The severe Duchenne muscular dystrophy (DMD)and the more benign Becker muscular dystrophy (BMD)are allelic disorders of the dystrophin gene located at Xp21 (1, 2) . The dystrophin gene consists of 79 exons spread over more than 2,500 kb of the chromosome (3) . Approximately two-thirds of DMDor BMDpatients carry deletions in their dystrophin gene (4) . The dystrophin immunohistochemistry of the skeletal muscle shows a negative staining pattern in DMD. In BMD, discontinuous patchy staining pattern was thought to be characteristic (5, 6) . However, it has been proved that the staining pattern varies from negative to nearly normal according to the specificity of the antibodies used (7) . BMDis marked by late onset and slowly progressive muscular degeneration, compared with DMD.However, BMDis knownto show a wide clinical spectrum (8) . BMDpatients with dilated cardiomyopathy, albeit rarely, have been reported (9) (10) (11) (12) (13) . These observations led to speculation that a genetic abnormality of dystrophin may be present in patients with X-linked cardiomyopathy (XLCM). XLCM is a rapidly progressive primary myocardial disorder presenting as congestive heart failure in teenage males without clinical signs of skeletal myopathy (14) .
Wehad the opportunity to examine a family with BMD presenting with cardiac involvement. While the proband manifested dilated cardiomiopathy and muscle weakness, one of his brothers showed only an electrocardiographical abnormality and did not show muscle weakness, despite carrying the same mutation in the dystrophin gene as the proband.
Case Report
A pedigree was constructed for the family (Fig. 1) . The proband (Subject IV-3) was a 41-year-old Japanese man with normal intelligence. He was a greengrocer and had experienced difficulty in running and lifting a load weighing more than 20 kg for past three years prior to the current hospitalization. He also noted atrophy of the thighs since 1990 (40 years of age).
Exertional dyspnea developed in September 199 1 (41 years of age). In November 1 99 1 , he consulted our hospital complaining of exertional dyspnea and muscle weakness. On admission, blood pressure was 1 10/74 mmHg, and the pulse rate was regular and 78 beats/min. A third cardiac sound was audible. Hepatomegaly with slight tenderness was also noted. Muscle strength in the extremities was decreased, with predilection in the proximal area. The thighs were atrophic and calves were hypertrophic. Deep tendon reflexes were normal. There was no sensory disturbance, pathologic reflex or ataxia. Waddling gait and Gowers' sign were negative. Cardiomegaly was noted on chest roentgenogram (CTRof 56%). Electrocardiogram (ECG) of the proband is shown in Fig. 2A . High voltage (SV1+RV5=5Omm) and ST depression in leads I, V4, V5 and V6 indicated left ventricular hypertrophy. The R/S ratio in lead VI exceeded 1.0, suggesting the presence of a myocardial lesion in the posterior wall. Figure 3 shows the the antibodies employed, but the overall intensity was more severely decreased than that of the skeletal muscle (Fig. 4D) .
Physical examination, blood chemical analysis, ECG and echocardiogram studies of the family memberswere also performed. The proband had five brothers and two sisters (Fig.  1) . His mother and two brothers (Subjects III-2, IV-4 and IV-6 in Fig. 1 ) demonstrated elevated serum muscular enzyme activities (CK, LDHand aldolase). These two brothers also showed abnormal ECG findings. The fourth brother (39 years of age, Subject IV-4), showing muscle weakness, and had been diagnosed with BMDat another hospital. Figure 2B shows his electrocardiogram. The R/S ratio in lead VI exceeded 1.0 and the amplitude ofR decreased in leads V4, V5 and V6, suggesting the presence of a myocardial lesion in the posterior wall.
Echocardiogram revealed diffuse hypokinesis of the left ventricle. The fifth brother (35 years of age, Subject IV-6) did not showmuscle weakness. Hedemonstrated only an abnormal ECGas a presenting symptom (Fig. 2C ). Negative T waves were seen in the leads I, V5and V6, and the amplitude ofR in lead V5 suddenly decreased. These findings suggested the presence of a myocardial lesion in the lateral wall. His echocardiogram did not demonstrate abnormal wall motion. Dystrophin gene analysis was performed using peripheral blood cells from the family members ( 15) . The proband and the two brothers with abnormal ECGs(Subjects IV-4, IV-6 in Fig.  1) were proved to have G-to-T transversion at the terminal nucleotide of exonl3 of the dystrophin gene, resulting in complete skipping ofexon 1 3 during the processing ofdystrophin pre-mRNA.The mother proved to be a heterozygote having the indicated mutation.
Discussion
Cardiac involvement is a frequent occurrence in DMDand BMD (16, 17) . The known manifestations of cardiac lesion in BMDvary: right-axis deviation and posterobasal or anterior wall 201T l perfusion defect ( 1 8), an echocardiographic configuration of hypertrophic cardiomyopathy ( 1 9), dilated cardiomyopathy (9-12), etc. Anan et al examined a cardiac biopsy specimen from a patient with BMDpresenting cardiomyopathy and evidenced the same dystrophic lesion in the cardiac muscle as in skeletal muscle, suggesting that cardiac involvement in Our case provided a link in understanding the relationship between BMDand XLCM.Three males in this family carried the same mutation in the dystrophin gene; G-to-T transversion at the terminal nucleotide of exonl3. However, muscle weakness was not found in the youngestbrother (Subject IV-6 in Fig.   1 ), although cardiac involvement was detected in all three brothers. In addition, clinically and pathologically, the degree of cardiac involvement was more advanced than skeletal muscle impairment in the proband. Therefore, we can say that the mutated dystrophin gene maycause cardiac involvement as a symptomprecedent to skeletal muscle involvement. Our results strongly support that at least a portion of XLCM cases are caused by a genetic abnormality of dystrophin.
